The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-N'1-[2-(5-Methyl-1H-pyrazol-4-yl)-thieno[3,2-d]pyrimidin-4-yl]-3-phenyl-propane-1,2-diamine ID: ALA3730583
PubChem CID: 89596296
Max Phase: Preclinical
Molecular Formula: C19H20N6S
Molecular Weight: 364.48
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1[nH]ncc1-c1nc(NC[C@@H](N)Cc2ccccc2)c2sccc2n1
Standard InChI: InChI=1S/C19H20N6S/c1-12-15(11-22-25-12)18-23-16-7-8-26-17(16)19(24-18)21-10-14(20)9-13-5-3-2-4-6-13/h2-8,11,14H,9-10,20H2,1H3,(H,22,25)(H,21,23,24)/t14-/m0/s1
Standard InChI Key: MCZSYSLIGBKUDS-AWEZNQCLSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
-1.0028 1.5132 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9971 -3.0138 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6168 1.4950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7582 2.9755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2262 3.2840 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.9732 1.9832 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.9669 0.8708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2067 -0.3050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2935 -3.7700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2878 -5.2708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2461 -5.8665 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.5842 -6.0270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5785 -7.5278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8731 -8.2854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8643 -9.7854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5609 -10.5278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2663 -9.7702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2750 -8.2702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
4 10 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 1 0
15 11 2 0
2 11 1 0
15 16 1 0
10 17 1 0
17 18 1 0
18 19 1 0
18 20 1 1
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 364.48Molecular Weight (Monoisotopic): 364.1470AlogP: 3.37#Rotatable Bonds: 6Polar Surface Area: 92.51Molecular Species: BASEHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.01CX Basic pKa: 9.73CX LogP: 2.65CX LogD: 1.40Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.49Np Likeness Score: -1.61
References 1. (2013) Thienopyrimidine inhibitors of atypical protein kinase C,